RxDoctor Payments Data

Taylor Dryden

Physician Assistant · Lincoln, RINPI 1710555180

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.6% of the total across 625 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $7,425, more than ten times the $523 reported in 2022. Among physician assistant clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,897in general payments, 2019–2025

Across 625 payments — averaging $23.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$3K
  • AbbVie$2K
  • LEO Pharma Inc.$1K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Novartis$766
  • UCB, Inc.$761
  • plus $6K from 25 others

What the payments were for

  • Travel & lodging$1601%
  • Food & beverage$14,39597%
  • Education$3422%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,897 in reported general payments places this provider in the 95th percentile of 481 physician assistant providers in Rhode Island.

See all physician assistant providers in Rhode Island

Medicare billing

Part B allowed, 2024
$70,082
Medicare patients
214
Services billed
1,185

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa12$260,942
Dupixent PenDupilumab25$105,653
Clobetasol Propionate157$7,506
Triamcinolone Acetonide234$2,192
Ketoconazole116$2,153
Clindamycin Phosphate44$1,821
Mupirocin247$1,781
Metronidazole28$1,506
Betamethasone Dipropionate36$1,273
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc26$1,070
Doxycycline Monohydrate42$983
Fluorouracil22$821
Nystatin48$646
Gentamicin Sulfate11$488
Ammonium Lactate19$459

Paid to pharmacies, not to this prescriber.

Other physician assistant in Lincoln

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →